Proliferative Diabetic Retinopathy - High Risk
3 clinical trials · Condition
◉ Watch Proliferative Diabetic Retinopathy - High Risk
| Record | Firm | Date |
|---|---|---|
| Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy (NCT06899529) | Christian Ophthalmic Surgery Expedition Network | 2025-03-20 |
| Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic Retinopathy (NCT06653361) | Hayatabad Medical Complex | 2022-09-01 |
| Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation (NCT02995629) | Wills Eye | 2016-03-01 |
Track Proliferative Diabetic Retinopathy - High Risk automatically
Every clearance here is in the API, with alerts when new ones post.